Featured Research

from universities, journals, and other organizations

Temple Using "Stomach Pacemaker" To Provide Relief For Chronic Nausea And Vomiting Associated With Gastroparesis

Date:
December 11, 2000
Source:
Temple University Health Sciences Center
Summary:
Doctors at Temple University Hospital are using an implantable "stomach pacemaker" that applies small electrical pulses to the stomach to provide relief for people suffering from severe, chronic nausea and vomiting associated with gastroparesis.

PHILADELPHIA -- Doctors at Temple University Hospital are using an implantable "stomach pacemaker" that applies small electrical pulses to the stomach to provide relief for people suffering from severe, chronic nausea and vomiting associated with gastroparesis. Gastroparesis is a stomach disorder in which food moves through the stomach more slowly than normal. This can result in severe, chronic nausea and vomiting that cannot always be controlled by medications. These patients have difficulty eating and, in severe cases, may require some form of tube feeding to ensure adequate nutrition.

The pacemaker -- officially called a gastric electrical stimulator -- is currently FDA-approved for compassionate use and is meant for patients for whom conventional drug therapy has failed. During the operation, which is performed under general anesthesia, the surgeon implants two small electrodes in the muscle wall of the stomach. The lead is then connected to the implantable neurostimulator that is placed beneath the skin, usually positioned below the rib cage and above the belt line in the abdomen. The pacemaker then emits 12 mild electrical pulses a minute to stimulate the stomach.

"Results of a clinical trial show that a majority of patients treated with the pacemaker experienced a reduction of vomiting episodes greater than 50 percent at 12 months," says Dr. Henry Parkman, director of Temple’s GI Motility Laboratory. "Patients also experienced improvements in other upper gastrointestinal symptoms, solid food intake, as well as significant improvements in health-related quality of life."


Story Source:

The above story is based on materials provided by Temple University Health Sciences Center. Note: Materials may be edited for content and length.


Cite This Page:

Temple University Health Sciences Center. "Temple Using "Stomach Pacemaker" To Provide Relief For Chronic Nausea And Vomiting Associated With Gastroparesis." ScienceDaily. ScienceDaily, 11 December 2000. <www.sciencedaily.com/releases/2000/12/001206080441.htm>.
Temple University Health Sciences Center. (2000, December 11). Temple Using "Stomach Pacemaker" To Provide Relief For Chronic Nausea And Vomiting Associated With Gastroparesis. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2000/12/001206080441.htm
Temple University Health Sciences Center. "Temple Using "Stomach Pacemaker" To Provide Relief For Chronic Nausea And Vomiting Associated With Gastroparesis." ScienceDaily. www.sciencedaily.com/releases/2000/12/001206080441.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins